First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric CancerXiaotian Zhang, Yanhua Chen, Qingxia Fan et al.|JAMA|2025Cited by 72
Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double-Blinded, Placebo-Controlled, Randomized Phase III Trial (ALTER0703)Yihebali Chi, Jianqiang Cai, Yongqian Shu et al.|The Oncologist|2021Cited by 64